INVITRO PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN CHRONIC-RENAL-FAILURE, CAPD AND HD

被引:70
作者
PEREIRA, BJG
POUTSIAKA, DD
KING, AJ
STROM, JA
NARAYAN, G
LEVEY, AS
DINARELLO, CA
机构
[1] NEW ENGLAND MED CTR,DIV GEOG MED & INFECT DIS,750 WASHINGTON ST,BOSTON,MA 02111
[2] NEW ENGLAND MED CTR,DEPT MED,BOSTON,MA
[3] ST ELIZABETH HOSP,DIV NEPHROL,BOSTON,MA
关键词
D O I
10.1038/ki.1992.436
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Dialysis-related symptoms are believed to be mediated, at least in part, by monocyte/macrophage-derived pro-inflammatory cytokines including interleukin-1 (IL-1) and tumor necrosis factor (TNF). Measuring the production of interleukin-1 receptor antagonist (IL-Ra), a naturally occurring inhibitor of IL-1. opens avenues to study the balance between these two cytokines in patients. We studied the cell content and production of IL-1beta and IL-Ra by unstimulated and endotoxin- or IgG-stimulated peripheral blood mononuclear cells (PBMC) in undialyzed patients with chronic renal failure (CRF). patients on continuous ambulatory peritoneal dialysis (CAPD) and patients on chronic hemodialysis with reuse cuprophan membranes (HD), and compared them to healthy controls. IL-1beta and IL-Ra were measured by specific radioimmunoassay. IL-1beta was undetectable in freshly harvested PBMC from healthy controls, CRF, CAPD or HD. In contrast, the content of IL-Ra in HD patients (2828 +/- 466 pg/ml) was significantly higher than that in healthy controls (643 +/- 53 pg/ml, P < 0.01), CRF (1097 +/- 320 pg/ml, P < 0.01) or CAPD (1398 +/- 390 pg/ml, P < 0.05). In endotoxin-stimulated PBMC, IL-1beta production by HD patients (9375 +/- 1687 pg/ml) was not significantly different from healthy controls (8429 +/- 1621 pg/ml). However, endotoxin-stimulated IL-Ra production by HD patients (32350 +/- 8276 pg/ml) was greater than that from healthy controls (11284 +/- 1250 pg/ml, P < 0.00 1), CRF (12263 +/-2680 pg/ml, P < 0.01) or CAPD patients (11822 +/- 1797 pg/ml, P < 0.01). In PBMC from healthy subjects, IgG and endotoxin induced similar amounts of IL-Ra (15117 +/- 3507 pg/ml and 11284 +/- 1250 pg/ml, respectively). In contrast IgG-stimulated IL-Ra production was significantly lower than that induced by endotoxin in patients with CRF (6312 +/- 1907 pg/ml vs. 12263 +/- 2680 pg/ml, P < 0.0001), CAPD (7906 +/- 3239 pg/ml vs. 11822 +/- 1797 pg/ml, P < 0.0001) and HD (15642 +/- 7181 pg/ml vs. 32350 +/- 8276 pg/ml, P < 0.0008). The relatively low levels of IL-Ra produced by uremic PBMC in response to IgG is consistent with defective Fc receptor number and/or function in patients with chronic renal failure. The present study demonstrates heightened production of IL-Ra in HD patients and suggests that IL-Ra may be a better indicator of host inflammatory response during HD than IL-1.
引用
收藏
页码:1419 / 1424
页数:6
相关论文
共 47 条
  • [1] ACCHIARDO SR, 1983, KIDNEY INT S, V24, pS99
  • [2] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    WELGUS, HG
    THOMPSON, RC
    EISENBERG, SP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) : 1694 - 1697
  • [3] ALTERED INTERLEUKIN-1 PRODUCTION IN PATIENTS UNDERGOING HEMODIALYSIS
    BLUMENSTEIN, M
    SCHMIDT, B
    WARD, RA
    ZIEGLERHEITBROCK, HWL
    GURLAND, HJ
    [J]. NEPHRON, 1988, 50 (04): : 277 - 281
  • [4] BRUNNER FP, 1989, REPLACEMENT RENAL FU, P697
  • [5] DINARELLO CA, 1991, BLOOD, V77, P1627
  • [6] CYTOKINES - AGENTS-PROVOCATEURS IN HEMODIALYSIS
    DINARELLO, CA
    HARRINGTON, JT
    KING, A
    KASSIRER, JP
    LEVEY, AS
    MEYER, K
    KURTIN, P
    GELFAND, J
    PEREIRA, BJG
    SINGH, A
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (03) : 683 - 694
  • [7] DINARELLO CA, 1981, J IMMUNOL, V127, P2517
  • [8] BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO
    DINARELLO, CA
    THOMPSON, RC
    [J]. IMMUNOLOGY TODAY, 1991, 12 (11): : 404 - 410
  • [9] PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST
    EISENBERG, SP
    EVANS, RJ
    AREND, WP
    VERDERBER, E
    BREWER, MT
    HANNUM, CH
    THOMPSON, RC
    [J]. NATURE, 1990, 343 (6256) : 341 - 346
  • [10] MEASUREMENT OF IMMUNOREACTIVE INTERLEUKIN-1-BETA FROM HUMAN MONONUCLEAR-CELLS - OPTIMIZATION OF RECOVERY, INTRASUBJECT CONSISTENCY, AND COMPARISON WITH INTERLEUKIN-1-ALPHA AND TUMOR NECROSIS FACTOR
    ENDRES, S
    GHORBANI, R
    LONNEMANN, G
    VANDERMEER, JWM
    DINARELLO, CA
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (03): : 424 - 438